1. KCND2 upregulation might be an independent indicator of poor survival in gastric cancer
   Hua Wei et al, 2018, Future Oncology CrossRef
2. KCND2: A prognostic biomarker and regulator of immune function in gastric cancer
   Hongying Zhou et al, 2023, Cancer Medicine CrossRef
3. Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers
   Andrea Polo et al, 2018, Scientific Reports CrossRef
4. Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats
   Nao Yukimatsu et al, 2019, Archives of Toxicology CrossRef
5. A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
   Xiangkun Wu et al, 2020, Frontiers in Immunology CrossRef
6. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa‐miR‐23b‐3p/KCND2 axis
   Guang‐Lin Lei et al, 2021, Environmental Toxicology CrossRef
7. Network-Based Analysis of Cognitive Impairment and Memory Deficits from Transcriptome Data
   Elif Emanetci et al, 2021, Journal of Molecular Neuroscience CrossRef